Abstract：Objective To explore the efficacy of cefoperazone sodium and sulbactam sodium in children with lower respiratory tract infection.Methods A total of 70 children with lower respiratory tract infection admitted to our hospital from December 2016 to December 2017 were selected as the research subjects,the children were randomly divided into the control group and the observation group according to the No.ID of the children,with 35 cases in each group.The control group was treated with Azithormycin,while the observation group was treated with cefoperazone sodium and sulbactam sodium,the clinical effects of the two groups were compared and analyzed,and the bacterial clearance rate was tested.The incidence of adverse reactions was compared between the two groups.Results The total effective rate of the observation group(94.28%)was significantly higher than that of the control group(77.14%),the difference was statistically significant(P＜0.05).The average clearance rate ofStreptococcus pneumoniae,Klebsiella pneumoniae,Escherichia coli,Pseudomonas aeruginosa,Enterobacter cloacae,Proteus and other pathogens in the observation group (91.43%)were significantly higher than those in the control group(71.43%),the differences were statistically significant(P＜0.05).The incidence of adverse reactions in the observation group (0.00%)was significantly lower than that in the control group (5.71%)(P＜0.05).Conclusion Cefoperazone Sodium Sulbactam Sodium in the treatment of children with lower respiratory tract infection has a significant effect,can improve the bacterial clearance rate,reduce the incidence of adverse reactions.
吴淑瑛. 头孢哌酮钠舒巴坦钠治疗小儿下呼吸道感染的临床效果[J]. 中国当代医药, 2018, 25(29): 73-75.
WU Shu-ying. Clinical efficacy of cefoperazone sodium and sulbactam sodium in treatment of children with lower respiratory tract infection. 中国当代医药, 2018, 25(29): 73-75.
京公网安备 11010502046607号